STING gain-of-function mutations have emerged in multiple systemic autoinflammatory diseases, including STING-associated vasculopathy with onset in infancy, systemic lupus erythematosus-like syndromes and familial chilblain lupus diseases [38,39,40,41,42,43,44,45,46,47,48]. Here, STING1 is linked to vascular disorder.